CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Lower risk of cross-contamination
4.1.2. Growing demand for biologics
4.1.3. Affordability and sustainability of single-use bioprocess technologies
4.1.4. Vaccine production using single-use disposable technologies
4.2. Market Restraints & Challenges
4.2.1. Growing market consolidation
4.2.2. Issues related to leachable and extractable
4.3. Market Opportunities
4.3.1. Booming biopharma industry in emerging countries
4.3.2. Contactless biometric authentication
CHAPTER 5. GLOBAL BIOPROCESS CONTAINER MARKET – BY TYPE
5.1. Introduction
5.2. 2D Bioprocess Containers
5.3. 3D Bioprocess Containers
5.4. Other Containers & Accessories
CHAPTER 6. GLOBAL BIOPROCESS CONTAINER MARKET – BY APPLICATION
6.1. Introduction
6.2. Upstream Processes
6.3. Downstream Processes
6.4. Process Development
CHAPTER 7. GLOBAL BIOPROCESS CONTAINER MARKET – BY END USER
7.1. Introduction
7.2. Biopharmaceutical companies
7.3. Life Science R&D companies
CHAPTER 8. GLOBAL BIOPROCESS CONTAINER MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL BIOPROCESS CONTAINER MARKET - COMPANY
PROFILES
9.1. Fujitsu Limited
9.2. Cogent Systems, Inc.
9.3. Fluid Controls Private Limited.
9.4. Rim Bio Inc.
9.5. Meissner.
9.6. Fenner PLC
9.7. Lonza Group.
9.8. Danaher Corporation.
9.9. The Merck Group
9.10. GE Healthcare.
9.11. Danaher Corporation.
9.12. ALLpaQ Packaging Group
9.13. The Sartorius group
9.14. Frontech Limited
9.15. NKT Group
9.16. ThermoFisherScientific
CHAPTER 10. GLOBAL BIOPROCESS CONTAINER MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
